These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22257231)

  • 21. Multicentric Castleman disease: report of rare disease in Kuwait.
    Mohammad BA; Al-Brahim N; Kunjhibava S; Ahmad M; Ahmad M
    Gulf J Oncolog; 2009 Jul; (6):48-50. PubMed ID: 20194090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimodality imaging and clinical features in Castleman disease: single institute experience in 30 patients.
    Hill AJ; Tirumani SH; Rosenthal MH; Shinagare AB; Carrasco RD; Munshi NC; Ramaiya NH; Howard SA
    Br J Radiol; 2015 May; 88(1049):20140670. PubMed ID: 25710283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and experimental study of Castleman disease in children.
    Zhang J; Li C; Lv L; Yang C; Kong XR; Zhu J; Zhang Y; Wang S
    Pediatr Blood Cancer; 2015 Jan; 62(1):109-14. PubMed ID: 25213773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Castleman disease--a case report].
    Kaczmarczyk D; Zimmer-Nowicka J; Jesionek-Kupnicka D; Niedźwiecka I; Golińska A; Morawiec-Sztandera A
    Otolaryngol Pol; 2008; 62(5):621-4. PubMed ID: 19004270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Rare Lymphoproliferative Disease: Castleman Disease.
    Gündüz E; Özdemir N; Bakanay ŞM; Karakuş S
    Turk J Haematol; 2021 Dec; 38(4):314-320. PubMed ID: 34719151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [PET-CT documented remission of multicentric Castleman disease after treatment with rituximab: case report and review].
    Adam Z; Szturz P; Koukalová R; Řehák Z; Pour L; Krejčí M; Šmardová L; Eid M; Volfová P; Čermáková Z; Křen L; Sokol F; Hanke I; Michalková E; Král Z; Mayer J
    Vnitr Lek; 2015 Mar; 61(3):251-9. PubMed ID: 25873122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Castleman disease: retrospective single-center study of therapeutic results in 10 patients].
    Szturz P; Adam Z; Rehák Z; Koukalová R; Sprláková-Puková A; Michalka J; Smardová L; Volfová P; Lengerová M; Mayer J
    Klin Onkol; 2013; 26(2):124-34. PubMed ID: 23718671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination.
    Kantarci FE; Eren R; Gündoğan C; Huq GE; Doğu MH; Suyanı E
    J Infect Chemother; 2016 Jul; 22(7):483-5. PubMed ID: 26948831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Castleman disease: an uncommon diagnosis in pediatrics.
    Vianna PM; Pastore PG; Cristofani L; Siqueira SAC; Aldred V; de Campos FPF; Zerbini MCN
    Autops Case Rep; 2012; 2(3):39-44. PubMed ID: 31528578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The full spectrum of Castleman disease: 273 patients studied over 20 years.
    Oksenhendler E; Boutboul D; Fajgenbaum D; Mirouse A; Fieschi C; Malphettes M; Vercellino L; Meignin V; Gérard L; Galicier L
    Br J Haematol; 2018 Jan; 180(2):206-216. PubMed ID: 29143319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A clinical case of Castleman's disease.
    Macedo JE; Abreu I; Marques M; Henrique R; Araújo A
    J Thorac Oncol; 2007 Mar; 2(3):259-60. PubMed ID: 17410052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Castleman disease in the pediatric neck: a literature review.
    Rabinowitz MR; Levi J; Conard K; Shah UK
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1028-36. PubMed ID: 23459702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical presentation of multicentric Castleman disease in a pediatric patient: pleural and pericardial effusion.
    Akman AO; Basaran O; Ozyoruk D; Han U; Sayli T; Cakar N
    Eur J Pediatr; 2016 Jun; 175(6):873-6. PubMed ID: 26614115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rare case report of hyaline-vascular type Castleman disease in the presacral region.
    Chang L; Wang S; Li J; Zhao Z; Wang M
    Front Oncol; 2024; 14():1434542. PubMed ID: 39252951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Castleman disease.
    Saeed-Abdul-Rahman I; Al-Amri AM
    Korean J Hematol; 2012 Sep; 47(3):163-77. PubMed ID: 23071471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multicentric Castleman disease not associated with HHV-8 and HIV viruses].
    Forteski Dde F; Netto FC; Lomonte AB; dos Anjos BC; Zerbini MC; Zerbini CA
    Rev Bras Reumatol; 2014; 54(4):326-9. PubMed ID: 25627230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orbital involvement in Castleman disease.
    Venizelos I; Papathomas TG; Papathanasiou M; Cheva A; Garypidou V; Coupland S
    Surv Ophthalmol; 2010; 55(3):247-55. PubMed ID: 20070998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis.
    Menke DM; Camoriano JK; Banks PM
    Mod Pathol; 1992 Sep; 5(5):525-30. PubMed ID: 1285353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Castelman disease of the parotid gland: An unusual entity.
    Temirbekov D; Yazici ZM; Ergelen R; Turgut H; Kayhan FT
    Otolaryngol Pol; 2014; 68(4):208-11. PubMed ID: 24981305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptomatic mesentery Castleman disease mimicking a pancreatic tumor.
    Su IH; Wan YL; Pan KT; Hung CF; Tseng JH; Hsieh CH; Liu NJ
    Clin Imaging; 2005; 29(5):348-51. PubMed ID: 16153543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.